KR
Khosla Rachna Directrice du Développement Commercial
Other F
Insider track record Executive Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Khosla Rachna, Directrice du Développement Commercial. Director active across 1 company, notably AMGEN INC. In total, 39 disclosures have been logged. Split: 0 buy · 5 sells. Total volume traded: €1.9m. Activity tracked since 5 November 2021. The latest transaction was disclosed on 11 August 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Khosla Rachna Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 39 total
▼ SVP, Business Development · Executives · 11 Aug 2026 · AMGEN INC 2,000 shares @ US$412.567 0.0004% mcap 18.2% of flow Common Stock SEC:0000318154-26-000137:0
◇ SVP, Business Development · Executives · 13 Aug 2026 · AMGEN INC 1,252 shares @ US$162.60 0.0001% mcap 4.5% of flow Common Stock SEC:0000318154-26-000137:1
▼ SVP, Business Development · Executives · 13 Aug 2026 · AMGEN INC 1,252 shares @ US$416.4256 0.0002% mcap 11.5% of flow Common Stock SEC:0000318154-26-000137:2
● SVP, Business Development · Executives · 2 May 2026 · AMGEN INC 117 shares @ US$329.82 0.0000% mcap 3.5% of flow Common Stock SEC:0000318154-26-000065:0
● SVP, Business Development · Executives · 2 May 2026 · AMGEN INC 108 shares @ US$329.82 0.0000% mcap 3.2% of flow Common Stock SEC:0000318154-26-000065:1
● SVP, Business Development · Executives · 16 Mar 2026 · AMGEN INC 707 shares @ US$366.21 14.7% of flow Common Stock SEC:0000318154-26-000030:0
◆ SVP, Business Development · Executives · 3 Mar 2026 · AMGEN INC 1,876 shares 0Common Stock SEC:0000318154-26-000019:0
▼ SVP, Business Development · Executives · 12 Nov 2025 · AMGEN INC 890 shares @ US$336.2422 13.9% of flow Common Stock SEC:0000318154-25-000082:0
● SVP, Business Development · Executives · 5 Nov 2025 · AMGEN INC 226 shares @ US$296.70 3.6% of flow Common Stock SEC:0000318154-25-000076:0
▼ SVP, Business Development · Executives · 5 Jun 2025 · AMGEN INC 1,500 shares @ US$289.68 28.8% of flow Common Stock SEC:0001127602-25-017018:0
◆ SVP, Business Development · Executives · 6 May 2025 · AMGEN INC 610 shares 0Common Stock SEC:0001127602-25-013784:0
● SVP, Business Development · Executives · 2 May 2025 · AMGEN INC 110 shares @ US$283.78 2.9% of flow Common Stock SEC:0001127602-25-013531:0
● SVP, Business Development · Executives · 2 May 2025 · AMGEN INC 104 shares @ US$283.78 2.8% of flow Common Stock SEC:0001127602-25-013531:1
● SVP, Business Development · Executives · 30 Apr 2025 · AMGEN INC 74 shares @ US$288.56 2.0% of flow Common Stock SEC:0001127602-25-013284:0
● SVP, Business Development · Executives · 17 Mar 2025 · AMGEN INC 489 shares @ US$313.71 15.0% of flow Common Stock SEC:0001127602-25-010058:0
◆ SVP, Business Development · Executives · 3 Mar 2025 · AMGEN INC 1,403 shares 0Common Stock SEC:0001127602-25-008426:0
● SVP, Business Development · Executives · 5 Nov 2024 · AMGEN INC 212 shares @ US$316.91 6.6% of flow Common Stock SEC:0001127602-24-026628:0
◆ SVP, Business Development · Executives · 7 May 2024 · AMGEN INC 532 shares 0Common Stock SEC:0001127602-24-014856:0
● SVP, Business Development · Executives · 5 May 2024 · AMGEN INC 41 shares @ US$311.29 1.3% of flow Common Stock SEC:0001127602-24-014510:0
● SVP, Business Development · Executives · 2 May 2024 · AMGEN INC 74 shares @ US$277.37 2.0% of flow Common Stock SEC:0001127602-24-014352:0
● SVP, Business Development · Executives · 30 Apr 2024 · AMGEN INC 48 shares @ US$276.38 1.3% of flow Common Stock SEC:0001127602-24-014027:0
● SVP, Business Development · Executives · 18 Mar 2024 · AMGEN INC 438 shares @ US$268.87 11.5% of flow Common Stock SEC:0001127602-24-010856:0
◆ SVP, Business Development · Executives · 6 Mar 2024 · AMGEN INC 1,256 shares 0Common Stock SEC:0001127602-24-009245:0
● SVP, Business Development · Executives · 5 Nov 2023 · AMGEN INC 173 shares @ US$269.86 4.7% of flow Common Stock SEC:0001127602-23-026977:0
● SVP, Business Development · Executives · 5 Nov 2023 · AMGEN INC 144 shares @ US$269.86 3.9% of flow Common Stock SEC:0001127602-23-026977:1
25 of 39 declarations
Load more (14 remaining) About Khosla Rachna Khosla Rachna is Directrice du Développement Commercial and SVP, Business Development at AMGEN INC. She has 36 filings in total, and across the sampled recent filings, sales total 750067 EUR, with filings dated from 2021-11-09 to 2026-05-05; the stated transaction nature is Retenue fiscale.